UNSPSC 51142033: Propacetamol

This classification denotes an analgesic and antipyretic with the molecular formula C14H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5CHW4JMR82, chemically known as n,n-diethylglycine, ester with 4-hydroxyacetanilide but generally known as propacetamol, which bears US NIH Compound Identifier 68865. European Medicines Agency schedules Propacetamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10093MIG.

UNSPSC 51142033 Propacetamol, a Commodity code, does not map to the state and local procurement activity currently posted under this designation. The three most recent opportunities tagged to this code involve naloxone procurement, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceuticals and OTC products—none of which are propacetamol-specific purchases. The mismatch suggests either a cataloging error in the source system or that propacetamol itself sees little recent activity in state and local procurement compared to related analgesics and pharmaceutical supply categories.

The issuing bodies soliciting under these misaligned tags include a county health department (Seminole County, Florida), a state health and human services commission (Texas HHS), and a multistate cooperative purchasing alliance (Minnesota MMCAP, serving state, local, and participating jurisdictions in Oregon and beyond). The representative opportunities show activity in Florida, Texas, and the upper Midwest, with procurement vehicles spanning traditional IFB processes, exploratory RFIs to test market capacity, and cooperative purchasing RFPs. Absent a correction to code assignment or a broader sourcing pattern in propacetamol itself, business development professionals should verify the accuracy of this code's tagging before investing pursuit effort.